Shuttle Pharmaceuticals Holdings (SHPH) Long-Term Deferred Tax (2022 - 2025)

Shuttle Pharmaceuticals Holdings' Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $7.8 million for Q4 2025.

• In Q4 2025, Long-Term Deferred Tax rose 53.57% year-over-year to $7.8 million; the TTM figure through Dec 2025 stood at $7.8 million (up 53.57% YoY), while the FY2025 annual figure was $7.8 million, up 53.57% from the prior year.
• Long-Term Deferred Tax was $7.8 million for Q4 2025 at Shuttle Pharmaceuticals Holdings, up from $5.1 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $7.8 million in Q4 2025 to a low of $60196.0 in Q4 2022.
• Historically, Long-Term Deferred Tax has averaged $4.1 million across 4 years, with a median of $4.3 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Long-Term Deferred Tax soared 5596.62% in 2023, then jumped 47.95% in 2024.
• A 4-year view of Long-Term Deferred Tax shows it stood at $60196.0 in 2022, then jumped by 5596.62% to $3.4 million in 2023, then surged by 47.95% to $5.1 million in 2024, then jumped by 53.57% to $7.8 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $7.8 million (Q4 2025), $5.1 million (Q4 2024), and $3.4 million (Q4 2023), per Business Quant data.